HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Involvement of hepatic peroxisome proliferator-activated receptor α/γ in the therapeutic effect of osthole on high-fat and high-sucrose-induced steatohepatitis in rats.

Abstract
Our previous studies have indicated that osthole may be a dual agonist of peroxisome proliferator-activated receptor (PPAR) α/γ and decrease the hepatic lipid accumulation. But there has been no report about therapeutic effect on steatohepatitis. In the present study, we investigated the action of osthole and its potential mechanisms. The rats with steatohepatitis induced by orally feeding high-fat and high-sucrose emulsion were given osthole 5-20 mg/kg for 4 weeks. The results showed that after treatment with osthole, the serum alanine aminotransferase, aspartate aminotransferase, total cholesterol, triglyceride (TG), and free fatty acid (FFA) levels, the hepatic TG, FFA, tumor necrosis factor-α, monocyte chemotactic protein-1, interleukin-6, and interleukin-8 contents, and the hepatic weight and liver index were lowered, especially in the osthole 20 mg/kg group. The histological evaluation of liver specimens demonstrated that osthole might improve the hepatic steatosis and inflammation. At the same time, osthole treatment increased the hepatic protein expressions of PPARα/γ and lipoprotein lipase, and decreased the hepatic protein expressions of nuclear factor-κB, sterol regulatory element-binding protein-1c, fatty acid synthase, and diacylglycerol acyltransferase. These findings demonstrate that osthole is effective in treating rat steatohepatitis, and the PPARα/γ may be involved in the osthole-induced modulation of hepatic lipogenic gene expressions and inflammatory cytokine production.
AuthorsXi Zhao, Jie Xue, Xiao-Li Wang, Yan Zhang, Min Deng, Mei-Lin Xie
JournalInternational immunopharmacology (Int Immunopharmacol) Vol. 22 Issue 1 Pg. 176-81 (Sep 2014) ISSN: 1878-1705 [Electronic] Netherlands
PMID24993341 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier B.V. All rights reserved.
Chemical References
  • Coumarins
  • Cytokines
  • Inflammation Mediators
  • NF-kappa B
  • PPAR alpha
  • PPAR gamma
  • Sucrose
  • Cholesterol
  • Fatty Acid Synthases
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Lipoprotein Lipase
  • osthol
Topics
  • Alanine Transaminase (blood)
  • Animals
  • Aspartate Aminotransferases (blood)
  • Cholesterol (blood)
  • Coumarins (therapeutic use)
  • Cytokines (metabolism)
  • Diet, High-Fat
  • Fatty Acid Synthases (metabolism)
  • Gene Expression Regulation, Neoplastic (genetics)
  • Humans
  • Inflammation Mediators
  • Lipid Metabolism (drug effects)
  • Lipoprotein Lipase (genetics, metabolism)
  • Liver (drug effects, metabolism, pathology)
  • Male
  • NF-kappa B (metabolism)
  • Non-alcoholic Fatty Liver Disease (drug therapy, immunology, metabolism)
  • PPAR alpha (genetics, metabolism)
  • PPAR gamma (genetics, metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Sucrose (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: